Baystate Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $152K | Sell |
287
-12
| -4% | -$6.38K | 0.01% | 229 |
|
|
2023
Q3 | $152K | Sell |
299
-22
| -7% | -$11.2K | 0.01% | 218 |
|
|
2023
Q2 | $168K | Buy |
321
+219
| +215% | +$114K | 0.01% | 204 |
|
|
2023
Q1 | $59.1K | Buy |
102
+20
| +24% | +$11.6K | 0.01% | 315 |
|
|
2022
Q4 | $45K | Buy |
82
+22
| +37% | +$12.1K | ﹤0.01% | 345 |
|
|
2022
Q3 | $31K | Buy |
60
+2
| +3% | +$1.03K | ﹤0.01% | 372 |
|
|
2022
Q2 | $32K | Sell |
58
-25
| -30% | -$13.8K | ﹤0.01% | 378 |
|
|
2022
Q1 | $49K | Buy |
83
+21
| +34% | +$12.4K | ﹤0.01% | 323 |
|
|
2021
Q4 | $42K | Buy |
62
+22
| +55% | +$14.9K | ﹤0.01% | 350 |
|
|
2021
Q3 | $23K | Sell |
40
-11
| -22% | -$6.33K | ﹤0.01% | 400 |
|
|
2021
Q2 | $26K | Hold |
51
| – | – | ﹤0.01% | 361 |
|
|
2021
Q1 | $23K | Hold |
51
| – | – | ﹤0.01% | 349 |
|
|
2020
Q4 | $24K | Sell |
51
-63
| -55% | -$29.6K | ﹤0.01% | 329 |
|
|
2020
Q3 | $50K | Sell |
114
-7
| -6% | -$3.07K | 0.01% | 224 |
|
|
2020
Q2 | $44K | Sell |
121
-1,092
| -90% | -$397K | 0.01% | 235 |
|
|
2020
Q1 | $344K | Buy |
1,213
+72
| +6% | +$20.4K | 0.05% | 79 |
|
|
2019
Q4 | $371K | Buy |
1,141
+1
| +0.1% | +$325 | 0.05% | 79 |
|
|
2019
Q3 | $332K | Buy |
1,140
+900
| +375% | +$262K | 0.04% | 81 |
|
|
2019
Q2 | $72K | Sell |
240
-22
| -8% | -$6.6K | 0.01% | 178 |
|
|
2019
Q1 | $69K | Buy |
262
+13
| +5% | +$3.42K | 0.01% | 179 |
|
|
2018
Q4 | $60K | Hold |
249
| – | – | 0.01% | 181 |
|
|
2018
Q3 | $57K | Buy |
249
+200
| +408% | +$45.8K | 0.01% | 187 |
|
|
2018
Q2 | $10K | Hold |
49
| – | – | ﹤0.01% | 378 |
|
|
2018
Q1 | $11K | Hold |
49
| – | – | ﹤0.01% | 353 |
|
|
2017
Q4 | $11K | Sell |
49
-71
| -59% | -$15.9K | ﹤0.01% | 362 |
|
|
2017
Q3 | $23K | Hold |
120
| – | – | ﹤0.01% | 272 |
|
|
2017
Q2 | $22K | Buy |
120
+9
| +8% | +$1.65K | ﹤0.01% | 270 |
|
|
2017
Q1 | $17K | Buy |
111
+40
| +56% | +$6.13K | ﹤0.01% | 289 |
|
|
2016
Q4 | $10K | Buy |
+71
| New | +$10K | ﹤0.01% | 303 |
|
|
2013
Q3 | – | Sell |
-23
| Closed | -$2K | – | 213 |
|
|
2013
Q2 | $2K | Buy |
+23
| New | +$2K | ﹤0.01% | 276 |
|